loading…
J0593 Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
BackJ0013Esketamine, nasal spray, 1 mg→J0120Injection, tetracycline, up to 250 mg→J0121Injection, omadacycline, 1 mg→J0122Injection, eravacycline, 1 mg→J0129Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)→J0130Injection abciximab, 10 mg→J0131Injection, acetaminophen, not otherwise specified,10 mg→J0132Injection, acetylcysteine, 100 mg→J0133Injection, acyclovir, 5 mg→J0134Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg→J0136Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg→J0137Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg→J0138Injection, acetaminophen 10 mg and ibuprofen 3 mg→J0139Injection, adalimumab, 1 mg→J0153Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)→J0162Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg→J0163Injection, epinephrine in sodium chloride (endo), 0.1 mg→J0164Injection, epinephrine in sodium chloride (baxter), 0.1 mg→J0165Injection, epinephrine, not otherwise specified, 0.1 mg→J0166Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg→J0167Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg→J0168Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg→J0169Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg→J0174Lecanemab-irmb, for intravenous injection, 1 mg→J0175Injection, donanemab-azbt, 2 mg→J0177Injection, aflibercept hd, 1 mg→J0178Injection, aflibercept, 1 mg→J0179Injection, brolucizumab-dbll, 1 mg→J0180Injection, agalsidase beta, 1 mg→J0184Injection, amisulpride, 1 mg→J0185Injection, aprepitant, 1 mg→J0202Injection, alemtuzumab, 1 mg→J0206Injection, allopurinol sodium, 1 mg→J0207Injection, amifostine, 500 mg→J0208Injection, sodium thiosulfate (pedmark), 100 mg→J0209Injection, sodium thiosulfate (hope), 100 mg→J0210Injection, methyldopate hcl, up to 250 mg→J0211Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)→J0216Injection, alfentanil hydrochloride, 500 micrograms→J0217Injection, velmanase alfa-tycv, 1 mg→J0218Injection, olipudase alfa-rpcp, 1 mg→J0219Injection, avalglucosidase alfa-ngpt, 4 mg→J0220Injection, alglucosidase alfa, 10 mg, not otherwise specified→J0221Injection, alglucosidase alfa, (lumizyme), 10 mg→J0222Injection, patisiran, 0.1 mg→J0223Injection, givosiran, 0.5 mg→J0224Injection, lumasiran, 0.5 mg→J0225Injection, vutrisiran, 1 mg→J0248Injection, remdesivir, 1 mg→J0256Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg→J0257Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg→J0270Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)→J0275Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)→J0278Injection, amikacin sulfate, 100 mg→J0280Injection, aminophyllin, up to 250 mg→J0281Injection, aminocaproic acid, 1 gram→J0282Injection, amiodarone hydrochloride, 30 mg→J0283Injection, amiodarone hydrochloride (nexterone), 30 mg→J0285Injection, amphotericin b, 50 mg→J0287Injection, amphotericin b lipid complex, 10 mg→J0289Injection, amphotericin b liposome, 10 mg→J0290Injection, ampicillin sodium, 500 mg→J0291Injection, plazomicin, 5 mg→J0295Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm→J0300Injection, amobarbital, up to 125 mg→J0330Injection, succinylcholine chloride, up to 20 mg→J0348Injection, anidulafungin, 1 mg→J0349Injection, rezafungin, 1 mg→J0360Injection, hydralazine hcl, up to 20 mg→J0364Injection, apomorphine hydrochloride, 1 mg→J0390Injection, chloroquine hydrochloride, up to 250 mg→J0391Injection, artesunate, 1 mg→J0400Injection, aripiprazole, intramuscular, 0.25 mg→J0401Injection, aripiprazole (abilify maintena), 1 mg→J0402Injection, aripiprazole (abilify asimtufii), 1 mg→J0456Injection, azithromycin, 500 mg→J0457Injection, aztreonam, 100 mg→J0458Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg)→J0461Injection, atropine sulfate, 0.01 mg→J0462Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg→J0463Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg→J0470Injection, dimercaprol, per 100 mg→J0475Injection, baclofen, 10 mg→J0476Injection, baclofen, 50 mcg for intrathecal trial→J0480Injection, basiliximab, 20 mg→J0485Injection, belatacept, 1 mg→J0490Injection, belimumab, 10 mg→J0491Injection, anifrolumab-fnia, 1 mg→J0500Injection, dicyclomine hcl, up to 20 mg→J0515Injection, benztropine mesylate, per 1 mg→J0517Injection, benralizumab, 1 mg→J0520Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg→J0525Injection, cefotetan disodium, 10 mg→J0528Injection, fosfomycin disodium, 20 mg→J0558Injection, penicillin g benzathine and penicillin g procaine, 100,000 units→J0561Injection, penicillin g benzathine, 100,000 units→J0565Injection, bezlotoxumab, 10 mg→J0567Injection, cerliponase alfa, 1 mg→J0570Buprenorphine implant, 74.2 mg→J0571Buprenorphine, oral, 1 mg→J0572Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine→J0573Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine→J0574Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine→J0575Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine→J0577Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy→J0578Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy→J0582Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg→J0583Injection, bivalirudin, 1 mg→J0584Injection, burosumab-twza 1 mg→J0585Injection, onabotulinumtoxina, 1 unit→J0586Injection, abobotulinumtoxina, 5 units→J0587Injection, rimabotulinumtoxinb, 100 units→J0588Injection, incobotulinumtoxin a, 1 unit→J0589Injection, daxibotulinumtoxina-lanm, 1 unit→J0591Injection, deoxycholic acid, 1 mg→J0592Injection, buprenorphine hydrochloride, 0.1 mg→J0593Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)→J0594injection, busulfan, 1 mg→J0595Injection, butorphanol tartrate, 1 mg→J0596Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units→J0597Injection, c-1 esterase inhibitor (human), berinert, 10 units→J0598Injection, c-1 esterase inhibitor (human), cinryze, 10 units→J0599Injection, c-1 esterase inhibitor (human), (haegarda), 10 units→J0600Injection, edetate calcium disodium, up to 1000 mg→J0601Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)→J0602Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)→J0603Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)→J0604Cinacalcet, oral, 1 mg, (for esrd on dialysis)→J0605Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)→J0606Injection, etelcalcetide, 0.1 mg→J0607Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)→J0608Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)→J0609Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)→J0612Injection, calcium gluconate, not otherwise specified, 10 mg→J0613Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg→J0614Injection, treosulfan, 50 mg→J0615Calcium acetate, oral, 23 mg (for esrd on dialysis)→J0616Injection, metoprolol tartrate, 1 mg→J0618Injection, calcium chloride, 2 mg→J0620Injection, calcium glycerophosphate and calcium lactate, per 10 ml→J0630Injection, calcitonin salmon, up to 400 units→J0636Injection, calcitriol, 0.1 mcg→J0637Injection, caspofungin acetate, 5 mg→J0638Injection, canakinumab, 1 mg→J0641Injection, levoleucovorin, not otherwise specified, 0.5 mg→J0642Injection, levoleucovorin (khapzory), 0.5 mg→J0643Injection, leucovorin calcium, not otherwise specified, 1 mg→J0644Injection, leucovorin calcium (avyxa), 1 mg→J0650Injection, levothyroxine sodium, not otherwise specified, 10 mcg→J0651Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg→J0652Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg→J0654Injection, liothyronine, 1 mcg→J0665Injection, bupivicaine, not otherwise specified, 0.5 mg→J0666Injection, bupivacaine liposome, 1 mg→J0668Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg→J0670Injection, mepivacaine hydrochloride, per 10 ml→J0675Injection, carboprost tromethamine, 0.1 mg→J0681Injection, ceftobiprole medocaril sodium, 3 mg→J0687Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg→J0688Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg→J0689Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg→J0690Injection, cefazolin sodium, 500 mg→J0691Injection, lefamulin, 1 mg→J0692Injection, cefepime hydrochloride, 500 mg→J0694Injection, cefoxitin sodium, 1 gm→J0695Injection, ceftolozane 50 mg and tazobactam 25 mg→J0696Injection, ceftriaxone sodium, per 250 mg→J0697Injection, sterile cefuroxime sodium, per 750 mg→J0698Injection, cefotaxime sodium, per gm→J0699Injection, cefiderocol, 10 mg→J0701Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg→J0702Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg→J0703Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg→J0706Injection, caffeine citrate, 5 mg→J0712Injection, ceftaroline fosamil, 10 mg→J0713Injection, ceftazidime, per 500 mg→J0714Injection, ceftazidime and avibactam, 0.5 g/0.125 g→J0716Injection, centruroides immune f(ab)2, up to 120 milligrams→J0717Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)→J0720Injection, chloramphenicol sodium succinate, up to 1 gm→J0725Injection, chorionic gonadotropin, per 1,000 usp units→J0735Injection, clonidine hydrochloride, 1 mg→J0736Injection, clindamycin phosphate, 300 mg→J0737Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg→J0738Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)→J0739Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)→J0740Injection, cidofovir, 375 mg→J0741Injection, cabotegravir and rilpivirine, 2mg/3mg→J0742Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg→J0743Injection, cilastatin sodium; imipenem, per 250 mg→J0744Injection, ciprofloxacin for intravenous infusion, 200 mg→J0745Injection, codeine phosphate, per 30 mg→J0750Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)→J0751Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)→J0752Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)→J0759Injection, clevidipine butyrate, 1 mg→J0770Injection, colistimethate sodium, up to 150 mg→J0775Injection, collagenase, clostridium histolyticum, 0.01 mg→J0780Injection, prochlorperazine, up to 10 mg→J0791Injection, crizanlizumab-tmca, 5 mg→J0799Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified→J0801Injection, corticotropin (acthar gel), up to 40 units→J0802Injection, corticotropin (ani), up to 40 units→J0834Injection, cosyntropin, 0.25 mg→J0840Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram→J0841Injection, crotalidae immune f(ab')2 (equine), 120 mg→J0850Injection, cytomegalovirus immune globulin intravenous (human), per vial→J0870Injection, imetelstat, 1 mg→J0871Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg→J0872Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg→J0873Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg→J0874Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg→J0875Injection, dalbavancin, 5 mg→J0877Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg→J0878Injection, daptomycin, 1 mg→J0879Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)→J0881Injection, darbepoetin alfa, 1 microgram (non-esrd use)→J0882Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)→J0883Injection, argatroban, 1 mg (for non-esrd use)→J0884Injection, argatroban, 1 mg (for esrd on dialysis)→J0885Injection, epoetin alfa, (for non-esrd use), 1000 units→J0887Injection, epoetin beta, 1 microgram, (for esrd on dialysis)→J0888Injection, epoetin beta, 1 microgram, (for non esrd use)→J0890Injection, peginesatide, 0.1 mg (for esrd on dialysis)→J0891Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)→J0892Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)→J0893Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg→J0894Injection, decitabine, 1 mg→J0895Injection, deferoxamine mesylate, 500 mg→J0896Injection, luspatercept-aamt, 0.25 mg→J0897Injection, denosumab, 1 mg→J0898Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)→J0899Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)→J0901Vadadustat, oral, 1 mg (for esrd on dialysis)→J0911Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis)→J0945Injection, brompheniramine maleate, per 10 mg→
Procedure codeCODABLE
J0593
Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
- Part
- HCPCS Level II
- J
- Drugs Administered Other than Oral Method
- J0
- J0013–J0945
Source
CMS — ICD-10-PCS FY2026, HCPCS Level II october 2026, Procedure Codes 2026.